Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DC Labs is a specialized healthcare and life sciences company focused on the development and manufacturing of advanced topical solutions and enzymatic treatments. The company is best known for its proprietary LP3 Enzyme System, which is utilized in its flagship brands, Zymox and Oratene, to manage chronic skin, ear, and oral conditions without the use of antibiotics. DC Labs operates as both a product developer and a contract manufacturer, providing high-quality formulations for the human and animal health markets. Their business model emphasizes non-invasive, enzyme-based therapeutic alternatives for inflammatory and infectious conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DC Labs.